@entity2643 -induced XXXX : three cases and a review of the literature.

@entity1 @entity2643 @entity137 @entity17 @entity9918 @entity13312 @entity908 @entity16 @entity305 @entity5011 @entity943 @entity121
OBJECTIVES: To better characterize the clinical, electrodiagnostic, and pathologic aspects of @entity2643 -induced @entity9918 . METHODS: We reviewed medical records, performed electrodiagnostic studies, and examined histopathologic specimens of muscle and nerve in three @entity1 with @entity2643 -induced @entity137 , as well as summarized the relevant literature. RESULTS: Two @entity1 had a slightly asymmetric, mixed, but primarily demyelinating @entity305 . One also had a substantial @entity121 . The third had an acute @entity16 resembling @entity5011 . Seemingly, @entity908 kinase levels did not correlate with clinical or electromyographic evidence of @entity121 . Histologic evaluations of peripheral nerves revealed @entity17 , some axon loss, and a variable number of characteristic lysosomal inclusions. Muscle specimens from two @entity1 showed evidence of a @entity13312 . After discontinuation of @entity2643 , two @entity1 improved and one died of @entity943 . CONCLUSIONS: Although the clinical features and onset times vary, @entity2643 @entity137 manifests as a mixed @entity305 , @entity13312 , or both. @entity908 kinase levels may not correlate with the degree of @entity121 . Variable numbers of lysosomal inclusions in peripheral nerve, endothelial cells, and muscle are characteristic.
